These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 33158605)

  • 21. Viruses, parkinsonism and Parkinson's disease: the past, present and future.
    Leta V; Urso D; Batzu L; Lau YH; Mathew D; Boura I; Raeder V; Falup-Pecurariu C; van Wamelen D; Ray Chaudhuri K
    J Neural Transm (Vienna); 2022 Sep; 129(9):1119-1132. PubMed ID: 36036863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An educational case series of Parkinson's disease during the COVID-19 pandemic.
    Lo Monaco MR; Colacicco G; Marotta J; Bentivoglio AR;
    Rev Neurol (Paris); 2021; 177(1-2):134-136. PubMed ID: 32951860
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of home confinement during COVID-19 pandemic on Parkinson's disease.
    Kumar N; Gupta R; Kumar H; Mehta S; Rajan R; Kumar D; Kandadai RM; Desai S; Wadia P; Basu P; Mondal B; Sanchita ; Rawat A; Meka SS; Mishal B; Prashanth LK; Srivastava AK; Goyal V
    Parkinsonism Relat Disord; 2020 Nov; 80():32-34. PubMed ID: 32937224
    [No Abstract]   [Full Text] [Related]  

  • 24. Parkinson's Disease and Post-COVID-19 Syndrome: The Parkinson's Long-COVID Spectrum.
    Leta V; Rodríguez-Violante M; Abundes A; Rukavina K; Teo JT; Falup-Pecurariu C; Irincu L; Rota S; Bhidayasiri R; Storch A; Odin P; Antonini A; Ray Chaudhuri K
    Mov Disord; 2021 Jun; 36(6):1287-1289. PubMed ID: 33890344
    [No Abstract]   [Full Text] [Related]  

  • 25. Exploring the relationship between novel Coronavirus pneumonia and Parkinson's disease.
    Xi X; Han L
    Medicine (Baltimore); 2022 Nov; 101(46):e31813. PubMed ID: 36401405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
    Rejdak K; Grieb P
    Mult Scler Relat Disord; 2020 Jul; 42():102163. PubMed ID: 32388458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reply to: "Can the 2019 Novel Coronavirus Cause Parkinson's Disease?".
    Achbani A; Sine H; Naciri A; Baba MA; Kharbach A; Bouchriti Y; Nejmeddine M
    Mov Disord; 2020 Oct; 35(10):1726. PubMed ID: 33068480
    [No Abstract]   [Full Text] [Related]  

  • 28. May Parkinson's disease be a protective factor against CNS involvement by SARS-CoV2?
    Spina Tensini F; Spina Tensini T; Franklin GL; Teive HAG
    Parkinsonism Relat Disord; 2020 Aug; 77():20. PubMed ID: 32575004
    [No Abstract]   [Full Text] [Related]  

  • 29. A case of probable Parkinson's disease after SARS-CoV-2 infection.
    Cohen ME; Eichel R; Steiner-Birmanns B; Janah A; Ioshpa M; Bar-Shalom R; Paul JJ; Gaber H; Skrahina V; Bornstein NM; Yahalom G
    Lancet Neurol; 2020 Oct; 19(10):804-805. PubMed ID: 32949534
    [No Abstract]   [Full Text] [Related]  

  • 30. What can Parkinson's disease teach us about COVID-19?
    Tipton PW; Wszolek ZK
    Neurol Neurochir Pol; 2020; 54(2):204-206. PubMed ID: 32323862
    [No Abstract]   [Full Text] [Related]  

  • 31. Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?".
    Outeiro TF; Krisko A
    Mov Disord; 2021 Feb; 36(2):278-279. PubMed ID: 33599004
    [No Abstract]   [Full Text] [Related]  

  • 32. Human coronaviruses in idiopathic Parkinson's disease: Implications of SARS-CoV-2's modulation of the host's transcriptome.
    Vavougios GD
    Infect Genet Evol; 2021 Apr; 89():104733. PubMed ID: 33516970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 in Parkinson's disease: Report on prevalence and outcome.
    Artusi CA; Romagnolo A; Imbalzano G; Marchet A; Zibetti M; Rizzone MG; Lopiano L
    Parkinsonism Relat Disord; 2020 Nov; 80():7-9. PubMed ID: 32920322
    [No Abstract]   [Full Text] [Related]  

  • 34. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19-Induced Acute Bilateral Optic Neuritis.
    Sawalha K; Adeodokun S; Kamoga GR
    J Investig Med High Impact Case Rep; 2020; 8():2324709620976018. PubMed ID: 33238757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy.
    Merello M; Bhatia KP; Obeso JA
    Lancet Neurol; 2021 Feb; 20(2):94-95. PubMed ID: 33253627
    [No Abstract]   [Full Text] [Related]  

  • 37. In reply to: Helmich and Bloem (2020) "The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities".
    Edwards E; Carroll C
    J Parkinsons Dis; 2020; 10(3):1267-1268. PubMed ID: 32597820
    [No Abstract]   [Full Text] [Related]  

  • 38. Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Speeckaert MM; Speeckaert R; Delanghe JR
    Mov Disord; 2020 Sep; 35(9):1497. PubMed ID: 33400280
    [No Abstract]   [Full Text] [Related]  

  • 39. Viral Infection-Induced Gut Dysbiosis, Neuroinflammation, and α-Synuclein Aggregation: Updates and Perspectives on COVID-19 and Neurodegenerative Disorders.
    Follmer C
    ACS Chem Neurosci; 2020 Dec; 11(24):4012-4016. PubMed ID: 33244974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's Disease and COVID-19: Do We Need to Be More Patient?
    Gonzalez-Latapi P; Fearon C; Fasano A; Lang AE
    Mov Disord; 2021 Feb; 36(2):277. PubMed ID: 33599003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.